Skip to content
Adrienne Monson – Lifestyle
Author:
Ona Therapeutics
Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer
September 24, 2026
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
June 4, 2026